Immunovant, Inc.
IMVT · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$414 | -$259 | -$211 | -$157 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $49 | $41 | $32 | $34 |
| Change in WC | -$12 | $3 | -$11 | $15 |
| Other Non-Cash | $0 | $1 | $1 | $1 |
| Operating Cash Flow | -$376 | -$214 | -$188 | -$106 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $450 | $473 | $71 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4 | -$0 | $0 | $200 |
| Financing Cash Flow | $454 | $472 | $71 | $200 |
| Forex Effect | $1 | $1 | $0 | -$0 |
| Net Chg. in Cash | $79 | $259 | -$117 | $94 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $635 | $377 | $494 | $400 |
| End Cash | $714 | $635 | $377 | $494 |
| Free Cash Flow | -$377 | -$215 | -$188 | -$106 |